Insulet
PODD
#2032
Rank
NZ$17.28 B
Marketcap
NZ$249.18
Share price
-1.80%
Change (1 day)
-57.71%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2026 (TTM): NZ$1.06 Billion

According to Insulet's latest financial reports the company's current earnings are NZ$3.18 Billion. In 2025 the company made an earning of NZ$0.72 Billion, an increase over its 2024 earnings that were of NZ$0.62 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$1.06 B47.4%
2025 NZ$0.72 B16.3%
2024 NZ$0.62 B36.76%
2023 NZ$0.45 B481.9%
2022 NZ$78.12 M-45.24%
2021 NZ$0.14 B43.35%
2020 NZ$99.51 M18.51%
2019 NZ$83.97 M41.16%
2018 NZ$59.49 M-711.95%
2017 -NZ$9.73 Million-56.85%
2016 -NZ$22.54 Million-79.31%
2015 -NZ$0.11 Billion63.85%
2014 -NZ$66.48 Million31.04%
2013 -NZ$50.73 Million-21.96%
2012 -NZ$65.01 Million
2010 -NZ$62 Million-42.38%
2009 -NZ$0.11 Billion-33.56%
2008 -NZ$0.17 Billion65.93%
2007 -NZ$97.61 Million209.75%
2006 -NZ$31.52 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$33.93 B 2,977.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$13.08 B 1,086.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$13.28 B 1,104.47%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
NZ$63.02 B 5,614.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-NZ$0.12 Billion-110.03%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
NZ$0.15 B-86.38%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
NZ$2.31 B 109.70%๐Ÿ‡บ๐Ÿ‡ธ USA